Thought Leadership & Other Media

AGC Biologics is Attending ASGCT May 11-14, 2021 and Presenting Our Scalable LVV Production Process and Large-Scale AAV Manufacturing Development Data

Events Cell & Gene Therapy

We're pleased to announce that we will be attending ASGCT this year, running virtually from May 11 through the 14. Be sure to save some time to meet with our team, check out our two abstracts and presentations on lentiviral vector (LVV) and adeno-associated virus (AAV) – both of which we're thrilled to share with you and the community.  

AGC Biologics is Attending Meeting on the Med, April 6-9, 2021 as a Gold and Agenda-Level Sponsor – Register Now for Access

Events Cell & Gene Therapy

AGC Biologics is a proud sponsor of Alliance for Regenerative Medicine's (ARM) Meeting on the Mediterranean virtual conference this April.  While we wish we could spend time with everyone in person, we know this event is going to be the next best thing. (Hopefully we can be together again next year!)

Video: BIO-Europe 2020 Presentation: AGC Biologics' Capabilities and Introduction to Cell and Gene Therapy

Events Thought Leadership Cell & Gene Therapy

Byron Kneller, VP, Process Development, Seattle and Luca Alberici, General Manager, Milan, present AGC Biologics’ end-to-end CDMO protein expression and cell and gene therapy manufacturing capabilities at BIO-Europe in October, 2020. 

Follow Us
Join us on LinkedIn Follow us on Twitter